The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States
Author(s) -
Colleen S. Kraft,
Angela Hewlett,
Scott A. Koepsell,
Anne Winkler,
Christopher J. Kratochvil,
LuAnn Larson,
Jay B. Varkey,
Aneesh K. Mehta,
G. Marshall Lyon,
Rachel FriedmanMoraco,
Vincent C. Marconi,
Charles E. Hill,
James N. Sullivan,
Daniel W. Johnson,
Steven J. Lisco,
Mark J. Mulligan,
Timothy M. Uyeki,
Anita K. McElroy,
Tara K. Sealy,
Shelley Campbell,
Christina F. Spiropoulou,
Ute Ströher,
Ian Crozier,
Richard Sacra,
Michael Connor,
Viranuj Sueblinvong,
Harold A. Franch,
Philip W. Smith,
Bruce S. Ribner
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ334
Subject(s) - medicine , ebola virus , convalescent plasma , outbreak , disease , intensive care medicine , clinical trial , covid-19 , emergency medicine , virology , infectious disease (medical specialty)
The current West Africa Ebola virus disease (EVD) outbreak has resulted in multiple individuals being medically evacuated to other countries for clinical management.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom